Search results for "Hepatitis E virus"

showing 9 items of 9 documents

Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder.

2017

International audience; BACKGROUND & AIM:Several types of unexplained extra-hepatic manifestations, including haematological disorders, have been reported in the context of hepatitis E virus (HEV) infection. However, the underlying mechanism(s) of these manifestations are unknown. We provide evidence that HEV has an extra-hepatic endothelial tropism that can engage cutaneous T cells towards clonality.METHODS:A patient with a CD30(+) cutaneous T cell lymphoproliferative disorder (T-LPD) and biopsy-proven chronic HEV infection received three rounds of oral ribavirin treatment, administered either without or with interferon, and eventually achieved a sustained virologic response (SVR). Patholo…

0301 basic medicineMaleSkin NeoplasmsLymphomaLymphomatoid papulosisT cellLymphoproliferative disordersKi-1 Antigen[SDV.CAN]Life Sciences [q-bio]/CancerExtra-hepatic manifestationNHL[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health sciencesInterleukin 210302 clinical medicineEndothelial cellInterferonHepatitis E virusMedicineHumansCD30-positive cutaneous T cell lymphoproliferative disorderTropismHepatologybusiness.industryvirus diseasesMiddle Agedmedicine.diseaseVirologyHepatitis ELymphoma T-Cell CutaneousViral Tropism030104 developmental biologymedicine.anatomical_structureHEVImmunologyTissue tropism030211 gastroenterology & hepatologybusinessMemory T cellCD8medicine.drugJournal of hepatology
researchProduct

Assessment of ISO Method 15216 to Quantify Hepatitis E Virus in Bottled Water

2020

Hepatitis E virus (HEV) is one of the causative agents of water-borne human viral hepatitis and considered in Europe an emerging zoonotic pathogen. Analysis of bottled water through a standard method validated for HEV can contribute towards the risk management of this hazard. Putting some recent reports by the European Food Safety Authority in place, this study aimed to assess the performance of the concentration and extraction procedures described in ISO 15216-1:2017 for norovirus and hepatitis A virus on HEV detection. Following the ISO recommendation, the bottled water samples were spiked using serially diluted HEV fecal suspensions together with mengovirus as process control and concent…

0301 basic medicineMicrobiology (medical)viruses010501 environmental sciencesmedicine.disease_cause01 natural sciencesMicrobiologyArticleVirus03 medical and health sciencesConcentration methodsHepatitis E virusconcentration methodVirologymedicinelcsh:QH301-705.50105 earth and related environmental sciencesDetection limitChromatographyBottled waterChemistryExtraction (chemistry)RT-qPCRBottled watermedicine.diseaseTiter030104 developmental biologylcsh:Biology (General)NorovirusViral hepatitisHepatitis E Virus (HEV)
researchProduct

Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids

2018

The hepatitis E virus (HEV) is an emerging pathogen showing a considerable increase in the number of reported cases in Europe mainly related to the ingestion of contaminated food. As with other relevant viral foodborne pathogens, real-time reverse transcriptase polymerase chain reaction (RT-qPCR) is the gold standard for HEV detection in clinical, food, and environmental samples, but these procedures cannot discriminate between inactivated and potentially infectious viruses. Thus, the aim of this study was to develop a viability PCR method to discriminate between native, heat-, and high-pressure processing (HPP)-treated HEV using the hepatitis A virus (HAV) as a cultivable surrogate. To thi…

0301 basic medicineMicrobiology (medical)viruses030106 microbiologylcsh:QR1-502viability RT-qPCRBiologymedicine.disease_causeMicrobiologylcsh:Microbiologylaw.invention03 medical and health sciencesHepatitis E viruslawmedicineIngestionPolymerase chain reactionOriginal ResearchInfectivitybusiness.industryfoodborne virusGold standard (test)Food safetyVirologyReverse transcriptaseHAVfood safety030104 developmental biologyCapsidHEVbusinessintercalating dyeFrontiers in Microbiology
researchProduct

Hepatitis E virus in lettuce and water samples: A method-comparison study

2017

The hepatitis E virus (HEV), which is an increasing cause of acute viral hepatitis in Europe, is a zoonotic virus that is mainly transmitted through contaminated water, consumption of raw or undercooked meat from pigs or wild boar, blood transfusion, and organ transplantation. Although the role of HEV transmission through contaminated produce has not been confirmed, the presence of HEV has been reported in irrigation waters and in vegetables. The present study used a World Health Organization (WHO) international standard and clinical samples to evaluate the performance characteristics of three RT-qPCR assays for detection and quantification of HEV. Two of the evaluated assays provided good …

0301 basic medicineVeterinary medicineIrrigationMeatSwine030106 microbiologySewageReal-Time Polymerase Chain Reactionmedicine.disease_causeMicrobiology03 medical and health sciencesWild boarHepatitis E virusSpinacia oleraceabiology.animalPepperVegetablesHepatitis E virusmedicineAnimalsHumansDetection limitbiologySewagebusiness.industryWater PollutionRT-qPCRGeneral MedicineLettuceContaminationIrrigation watermedicine.diseaseHepatitis EEuropeHEVRNA ViralCapsicumViral hepatitisbusinessFoodborne virusFood Science
researchProduct

Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy

2011

Abstract Background Hepatitis E virus (HEV) is a major cause of acute hepatitis in developing countries, whereas it is not considered a major health problem in Western World. Aims To investigate the spread of HEV and its possible role in causing acute hepatitis in Southern Italy. Methods Four hundred and thirty patients observed from April to December 2009 were studied and grouped as follows: 55 individuals with acute hepatitis (AH), 33 of whom cryptogenic; 321 individuals with chronic liver diseases (CLD), (278 Italians and 43 immigrants); 54 individuals without liver disease (control-group). Serum samples from all cases were tested for IgG anti-HEV antibodies and those positive to this te…

AdultMalemedicine.medical_specialtyvirusesmedicine.disease_causeZOONOSISHepatitisLiver diseaseCHRONIC LIVER-DISEASEYoung AdultHepatitis E virusEpidemiologymedicineHepatitis E virusHumansAcute hepatitisHepatitis AntibodiesHepatologybiologybusiness.industryLiver DiseasesGastroenterologyvirus diseasesMiddle AgedHepatitis Emedicine.diseaseSerum samplesVirologydigestive system diseasesHepatitis EImmunoglobulin MItalyImmunoglobulin GChronic Diseasebiology.proteinRNA ViralFemaleAntibodycryptogenic Acute HepatitisbusinessHepatitis E virus infectionAcute hepatitisSerological diagnosis Hepatitis E Virus Acute hepatitis ZOONOSIS CHRONIC LIVER-DISEASE cryptogenic Acute HepatitisSerological diagnosis
researchProduct

Hepatitis E Virus Detection in Liver Tissue from Patients with Suspected Drug-Induced Liver Injury

2015

Hepatitis E virus (HEV) infection is increasingly recognized as a cause of acute hepatitis in the industrialized world. We aimed to determine the frequency of acute Hepatitis E virus (HEV) infection in cases of suspected drug-induced liver injury (DILI), mainly a diagnosis of exclusion. To this aim, formalin-fixed, paraffin-embedded (FFPE) liver tissues of all cases routinely processed in our institute during a 2 ½ years period in which DILI was amongst the differential diagnoses (157 liver biopsies, one liver explant) were subjected to semi-nested RT-PCR for the detection of hepatitis E virus (HEV) RNA. Histopathology was re-evaluated on all cases tested positive. HEV RNA was detectable in…

DrugPathologymedicine.medical_specialtymedia_common.quotation_subjectviruses610 Medicine & health2700 General Medicinemedicine.disease_causeliverHepatitis E virushepatitis E virus infection10049 Institute of Pathology and Molecular PathologyGenotypeHepatitis E virusmedicinehepatitismedia_commonLiver injuryHepatitislcsh:R5-920molecular testingbusiness.industryvirus diseasesGeneral Medicinemedicine.diseaseDiagnosis of exclusiondigestive system diseasesOriginal Research in MedicineEtiologyMedicineHistopathologylcsh:Medicine (General)businessdrug-induced liver injuryFrontiers in Medicine
researchProduct

HEV Occurrence in Waste and Drinking Water Treatment Plants

2020

Hepatitis E virus (HEV), particularly zoonotic genotype 3, is present in environmental waters worldwide, especially in industrialized countries. Thus, monitoring the presence of HEV in wastewater treatment plants (WWTPs) is an emerging topic due to the importance of reusing water on a global level. Given the limited data, this study aimed to monitor the occurrence of HEV in influent and effluent water in waste- and drinking-water treatment plants (WWTPs and DWTPs). To this end, different procedures to concentrate HEV in influent and effluent water from WWTPs and DWTPs were initially evaluated. The evaluated procedures resulted in average HEV recoveries of 15.2, 19.9, and 16.9% in influent, …

Microbiology (medical)Infective Doselcsh:QR1-502WastewateroccurrenceMicrobiologywater qualitylcsh:Microbiology03 medical and health sciencesHepatitis E virusDrinking waterEffluentwastewaterOriginal Research030304 developmental biology0303 health sciences030306 microbiologydrinking waterRT-qPCRRT-qPCR occurrenceContaminationPulp and paper industryWater qualityWastewaterEnvironmental scienceWater treatmentSewage treatmentWater qualityFrontiers in Microbiology
researchProduct

Structural characterization of site-modified nanocapsid with monodispersed gold clusters

2017

AbstractHepatitis E Virus-like particles self-assemble in to noninfectious nanocapsids that are resistant to proteolytic/acidic mucosal delivery conditions. Previously, the nanocapsid was engineered to specifically bind and enter breast cancer cells, where successful tumor targeting was demonstrated in animal models. In the present study, the nanocapsid surface was modified with a solvent-exposed cysteine to conjugate monolayer protected gold nanoclusters (AuNC). Unlike commercially available gold nanoparticles, AuNCs monodisperse in water and are composed of a discrete number of gold atoms, forming a crystalline gold core. Au102pMBA44 (Au102) was an ideal conjugate given its small 2.5 nm s…

lcsh:MedicineMetal NanoparticlesBioengineering02 engineering and technologyConjugated system010402 general chemistry01 natural sciencesElectronnanobiotechnologyArticleNanoclustersMaleimideschemistry.chemical_compoundMicroscopy Electron TransmissionMonolayerHepatitis E viruscapsidTransmissionNanotechnologylcsh:ScienceMaleimideCancerMicroscopyMultidisciplinaryLigandlcsh:RCryoelectron Microscopynanobiotekniikka021001 nanoscience & nanotechnologyCombinatorial chemistryRecombinant Proteins0104 chemical sciencesGood Health and Well BeingchemistryColloidal goldlcsh:QCapsid ProteinsnanohiukkasetnanoparticlesGold0210 nano-technologyLinkerConjugatekapsidi
researchProduct

Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta‐analysis

2020

Background and aims Hepatitis E is an infectious disease of the liver caused by the hepatitis E virus (HEV). Immunocompromised patients present a particular risk group, as chronification of hepatitis E leading to life-threatening cirrhosis occurs when these patients are infected. Therefore, this study aims to estimate and compare the anti-HEV seroprevalence and the rate of HEV RNA positivity in transplant recipients and patients with human immunodeficiency virus (HIV). Methods This systematic review and meta-analysis involved a literature search (PubMed, Scopus; 1,138 studies) including 120 studies from 1996 to 2019, reporting anti-HEV seroprevalence and/or HEV-RNA positivity. Statistical a…

medicine.medical_specialtyCirrhosisHIV InfectionsViremiamedicine.disease_causeImmunocompromised Host03 medical and health sciences0302 clinical medicineHepatitis E virusSeroepidemiologic StudiesInternal medicineHepatitis E virusmedicineHumansSeroprevalenceHepatitis AntibodiesViremiaHepatologybusiness.industryvirus diseasesmedicine.diseaseHepatitis EHepatitis ETransplantationChronic infectionImmunoglobulin G030220 oncology & carcinogenesisMeta-analysisRNA Viral030211 gastroenterology & hepatologybusinessLiver International
researchProduct